January Newsmakers

ICYMI at DUKE

Duke Departments

Evaluating Faith-Based Needs of Patients With Head and Neck Cancer (2022-2023) (Bass Connections)
Features Monica Bodd (MTS/MD student), Walter Lee, MD, MHS,
Nosayaba Osazuwa-Peters, PhD, MPH

4 Ph.D. Students Earn Fall 2022 Grants for Evolutionary Medicine Research (Duke Graduate School)
Features Rebecca Cook (PhD student, Evolutionary Anthropology)
Her project page
Plus
An evolutionary approach to inform pelvic implant shapes in patients with hip cancer: Fall 2022 Graduate Student Award in Cancer & Evolution (TriCEM)

Forward Together: Staying Close during a Breast Cancer Battle (Duke Today/Working at Duke)
Features Carmen Watson and Jacob Klapper, MD

Duke Relaunches Fence for the Fight Campaign (Go Duke)
Features Duke patient Elizabeth Beguinet

Data at Their Digital Fingertips: Tissue-based Research & Precision Cancer Medicine Comes of Age (Duke Pathology)
Features Carey Anders, MD, Michael Kastan, MD, PhD, Steve Patierno, PhD, Tomi Akinyemiju, PhD, Michael Datto, PhD, Shannon McCall, MD, and Jiaoti Huang, MD, PhD

Duke Senior Awarded George J. Mitchell Scholarship To Study Inflammatory Breast Cancer in Ireland (Duke Today)
Features Alexandra Bennion

Aravind Asokan to Lead Partnership with Danaher Corporation to Accelerate Gene Therapy Breakthroughs (Duke University School of Medicine)

How to Take Charge of Your Well-Being in 2023 (Working at Duke)
Features Liza Butler

2022 DUKE SURGERY ANNUAL REPORT PUBLISHED (Duke Surgery)
DCI faculty mentions include Georgia Beasley, MD, MHSc; Michael Lidsky, MD; Christopher Kontos, PhD; Garth Herbert, MD; Maggie DiNome, MD

Listening in on the Conversations of Fat Cells (Duke University School of Medicine Magnify)
Features Rana Gupta, PhD


Touching Lives Across North Carolina (Working at Duke)
Features Hannah Woriax, MD

Dr. Huang Gives Harold Cummins Endowed Lecture (Duke Pathology)
Features Jiaoti Huang, MD, PhD

From the Lab to Provost: Sally Kornbluth Looked to Help People Excel (Duke Today)
Features Sally Kornbluth, PhD

EDI Spotlight: Julius Wilder, MD, PhD (Duke University School of Medicine)

DCI Blog

ONE Team: Zullig & Oeffinger Help Patients Live Longer, Healthier
Features Leah Zullig, PhD, MPH, and Kevin Oeffinger, MD

McDonnells to be Honored at Caring House Annual Benefit
Features Donald McDonnell, PhD, and his wife Mary McDonnell

Fecci Co-Edits E-Book on Multi-D Approach to Brain Metastases
Features Peter Fecci, MD, PhD

At DCI’s Scientific Retreat, the Learning(s) Was Infectious
Features Meira Epplein, PhD; Katherine Garman, MD; Michael Kastan, MD, PhD; Steven Patierno, PhD; Julius Wilder, MD, PhD; Micah Luftig, PhD; Thomas LeBlanc, MD, MA; Kathryn Pollak, PhD; Kyle Lafata, PhD; Michael Deel, MD; Yiping He, PhD; Rui Yang, PhD; Zachary Hartman, PhD; along with Erika Crosby, PhD; Timothy Trotter, PhD; and H. Kim Lyerly, MD.

 
A Seismic Shift: Expanding the Reach of Precision Cancer Medicine
Features John Strickler, MD; Shannon McCall, MD; Michael Datto, MD, PhD; Michelle Green, PhD; Jiaoti Huang, MD, PhD;  Michael Kastan, MD, PhD; Matthew McKinney, MD; Bennett Caughey, MD; Andrew Armstrong, MD, MSc; Rhonda Bitting, MD; Nicholette T. Sloat, CGC, MA, MS; Tomi Akinyemiju, PhD, MS; Linda Sutton, MD.
 
Partners to the Core
Features Shannon McCall, MD; Michael Datto, MD, PhD; Jadee Neff, MD, PhD; Kouros Owzar, PhD; Shelley Hwang, MD, MHS; Austin Eckhoff, MD; Peter Allen, MD, PhD; Chanjuan Shi, MD, PhD; Avani Pendse, MD, PhD; Katherine Garman, MD, MHS; and William Jeck, MD, PhD; Carolyn Glass, MD, PhD; Andrew Nixon, PhD, MBA;
 
Duke Expands Footprint in Next-Gen Cancer Sequencing Tech
Features Catherine Rehder, PhD, FACMG; Sarah Rapisardo, PhD; Stefan Rentas, PhD; Shannon McCall, MD; Michael Datto, MD, PhD; William Jeck, MD, PhD

BRPC Milestones (2012-2022)
 
DCI 50th: Duke Med Alumni News Features DCI Investigators, Leaders
Features Arif Kamal, MD, MBA, MHS; Christopher Kontos, PhD; Daniel George, MD; Jennifer Freedman, PhD; John Strickler, MD; Matthew McKinney, MD; Michael Kastan, MD, PhD; Sandeep Dave, PhD; Scott Antonia, MD, PhD; Steve Patierno, PhD; Tammara Watts, MD, PhD; Tomi Akinyemiju, PhD; Trudy Oliver, PhD.

DCI Development Blog

WINTER 2022 BREAKTHROUGHS PUBLISHED 

A Sense of Peace
Features David Kirsch, MD, PhD, and Brian Brigman, MD.

Mission: Interception
Features Meira Epplein, PhD; Katherine Garman, MD, MHS; Steve Patierno, PhD; Shelley Hwang, MD; Evan Myers, MD, MPH; Austin Eckhoff, MD;

From the Lab to the Clinic: In Search of Early Diagnosis
Features Jim Abbruzzese, MD; Chris Counter, PhD; Ryne Ramaker (Hematology/oncology fellow); Siqi Li, PhD; Chris Counter, PhD.

Helping Duke Give Back to the World
Features Leslie Graves (DCI Board Member)
 

MEDIA

Duke doctor talks prevention during Cervical Cancer Awareness Month (CBS-17)
Features Brittany Davidson, MD

Duke researchers’ pancreatic cancer treatment method shows promise in early studies (CBS-17)
Features Ashutosh Chilkoti, PhD

R.J. Reynolds pivots to new cigarette pitches as flavor ban takes effect (New York Times)
Features Sven Jordt, PhD

Resolve to get preventative cancer screenings in 2023 (Billings Gazette (MT))
Features Lars Grimm, MD, MHS

Low screening rates for lung cancer persist in the U.S. (Philly Voice)
Features Jeffrey Crawford, MD

Best online Master’s in Nursing programs (U.S. News & World Report)
Features Duke University (#2)

TRADES, INDUSTRY, INSTITUTIONS, NONPROFITS, GOVT.

Tucatinib plus Trastuzumab approved for HER2+ colorectal cancer (Medscape) WATCH: FDA approval of Tucatinib plus Trastuzumab in mCRC (OncLive) FDA approves Tucatinib plus Trastuzumab for RAS Wild-Type, HeR2+ mCRC (Targeted Oncology) FDA approves Tukysa regimen for RAS wild-type, HER2-positive metastatic colorectal cancer (Healio) FDA OK’s first targeted treatment for HER2-positive colorectal cancer (Medpage Today) Tukysa combo approved for RAS wild-type, HER2-positive metastatic colorectal cancer (Medical Professional Resource) Tucatinib and Trastuzumab combination gains FDA approval for RAS wild-type HER2+ mCRC (Oncology Nursing News) Tukysa-Herceptin approval for colorectal cancer is an ‘important breakthrough’ for chemo-resistant disease, (Cure Today) Tucatinib approved as first treatment for HER2-positive metastatic CRC (Gastroenerology & Endoscopy News)
Features John Strickler, MD

Manipulating Data to Make Precision Medicine Magic (Association of Community Cancer Centers)
Features John Strickler, MD

NCI-funded centers study new ways to apply telehealth across cancer care (Healio)
Features Leah Zullig, PhD, MPH

Deescalating DCIS experts discuss new data from SABCS (Medscape)
Features Shelley Hwang, MD, MPH

NCCN Forum on Equity (NCCN)
Features Tamarra Watts, MD, PhD

Meet two new leaders improving diversity and equity across cancer centers (Cancer Health)
Features Tammara Watts, MD, PhD

Comparing costs of at-home colorectal screening tests (Cancer Today)
Features Julius Wilder, MD, PhD

Cancer Therapy–Related Hypertension (American Heart Association/ Hypertension)
Features Susan Dent, MD

LISTEN: A Conversation with ACCC Board Member Dr. Nadine Barrett (ACCC)
Features Nadine Barrett, PhD

WATCH: The Uptake of New Treatment Options for mHSPC in Real Life -- Education, Access, Use, and Diversity APCCC 2022 Presentation - Andrew Armstrong (Uro Today)
Features Andrew Armstrong, MD, MSc

WATCH: SABCS 2022 | Beyond anthracyclines and trastuzumab: cardiotoxicity of novel agents (VJ Oncology)
Features Susan Dent, MD

Where hospitals are spending their innovation dollars (Becker’s Hospital Review)
Features Duke Health

60 hospital and health systems with great oncology programs headed into 2023 (Becker’s Hospital Review)
Features Duke Cancer Center

Duke Health partners with nference to reveal HER insights, improve care (Fierce Healthcare)
*also carried by 12 additional outlets including in Pharma & Healthcare Monitor, Health IT Analytics
Features A. Eugene Washington, MD, MPH

70 oncology leaders on the move in 2022 (Becker’s Hospital Review)
Features Lee Zou, PhD

New data on DCIS surveillance imaging has experts concerned (Health Imaging)
Features Marc Ryser, PhD

Medtech in a minute (Medical Device & Diagnostic Industry)
Features Michael Abern, MD

Comparing Costs of At-Home Colorectal Screening Tests: Cologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard (Cancer Talk)
Features Julius Wilder, MD, PhD

Quantifying the difference between cellular distributions (Nashville Medical News)
Features Amanda Randles, PhD

Scientists use centrifuge to discover a hormone (The Scientist) Features Christopher Newgard, PhD

Dr. George on the Clinical Benefit of Phenotypic Evaluation in Prostate Cancer (OncLive)
Features Daniel George, MD

ADCs Represent One of Many Improvements in GU Cancer Treatment (OncLive)
Features Daniel George, MD

Dr. Harrison on the Effect of IO-Related Toxicities on Treatment Selection in RCC (OncLive)
Features Michael Harrison, MD

Opinion: A more diverse biomedical and healthcare workforce is within our reach (Modern Healthcare)
Features Kathryn Dickerson, MD, and Kafui Dzirasa, MD, PhD

WATCH: Dr. Force on the Efficacy of Trastuzumab Deruxtecan in the DESTINY-Breast02 Trial for HER2+ Breast Cancer (OncLive)
Features Jeremy Force, DO

Deep-learning system identifies difficult-to-detect brain metastases (Physics World)
Features Devon Godfrey, PhD


What a New Mammography Study Reveals About Surveillance Imaging in Women Treated for Ductal Carcinoma In Situ (Diagnostics & Imaging/Radiology)
Features Marc Ryser, PhD

SGO Wellness Committee publishes new study, “SGO and the elephant that is still in the room: Wellness, burnout, and gynecologic oncology” (SGO)
Features Brittany Davidson, MD

Healthcare access may affect receipt of therapy in ovarian cancer (Physician’s Weekly)
Features Mary Katherine Montes de Oca, MD

Guideline-directed cancer care can help reduce disparities, NCCN’s Schatz says (American Journal of Managed Care)
Features Mary Katherine Montes de Oca, MD


Evidence for “Tough Conversations” around racism in access to cancer care (Cancer Health)
Features Mary Katherine Montes de Oca, MD, and Tomi Akinyemiju, PhD

Black women less likely to receive guideline-concordant therapy for ovarian cancer (Healio)
Features Tomi Akinyemiju, PhD

SGO Wellness: Grief Needs Recognition (SGO)
Features Anthony Nicholas Galanos, MD, MA
 
Cooling brain tumor cells could make headway in glioblastoma, UTSW researcher finds (UTSW)
Features Syed Faaiz Enam, MBBS, PhD, (former Duke Biomedical Engineering student)
 

PAPERS

*Duke authors are bolded


Response to bipolar androgen therapy and PD-1 inhibition in a patient with metastatic castration-resistant prostate cancer and a germline CHEK2 mutation BMJ Case Reports January 2023 Benjamin T Berger, Matthew K Labriola, Emmanuel S Antonarakis, and Andrew J Armstrong.

Emotional, behavioral, and physical health consequences of loneliness in young adult survivors of childhood cancer: Results from the Childhood Cancer Survivor Study (Cancer) Chiara Papini PhD, Ameera A. Fayad PhD, RN, Mingjuan Wang MS, Fiona S. M. Schulte PhD, I-Chan Huang PhD, Yu-Ping Chang PhD, RN, Rebecca M. Howell PhD, Deokumar Srivastava PhD, Wendy M. Leisenring ScD, Gregory T. Armstrong MD, MSCE, Todd M. Gibson PhD, Leslie L. Robison PhD, Kevin C. Oeffinger MD, Kevin R. Krull PhD, Tara M. Brinkman PhD

Estrogen Receptor Signaling in the Immune System Endocrine Reviews Binita Chakraborty, Jovita Byemerwa, Taylor Krebs, Felicia Lim, Ching-Yi Chang, Donald P McDonnell

Natural product ligands of FKBP12: Immunosuppressive antifungal agents FK506, rapamycin, and beyond PLOS Pathogens Jan. 12, 2023 Angela Rivera, Joseph Heitman

End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy JCO Oncology Practice Jan. 11, 2023 Hannah E. Dzimitrowicz, MD; Lauren E. Wilson, PhD; Bradford E. Jackson , PhD; Lisa P. Spees, PhD; Christopher D. Baggett, PhD; Melissa A. Greiner, MS; Deborah R. Kaye, MD, MS; Tian Zhang, MD, MHS; Daniel George, MD; Charles D. Scales, Jr , MD, MSHS; Jessica E. Pritchard, PhD; Michael S. Leapman , MD; Cary P. Gross, MD; Michaela A. Dinan, PhD; and Stephanie B. Wheeler, PhD, MPH.

Cancer Therapy–Related Hypertension: A Scientific Statement From the American Heart Association Hypertension Jan 9, 2023 Jordana B. Cohen, Nancy J. Brown, Sherry-Ann Brown, Susan Dent, Daan C.H. van Dorst, Sandra M. Herrmann, Ninian N. Lang, Gavin Y. Oudit, Rhian M. Touyz and on behalf of the American Heart Association Council on Hypertension; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on the Kidney in Cardiovascular Disease

Deep Learning for Breast MRI Style Transfer with Limited Training Data Journal of Digital Imaging Dec. 21, 2022  Shixing Cao, Nicholas Konz, James Duncan & Maciej A. Mazurowski

Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study JNCCN Nov. 2022 Mary Katherine Montes de Oca MD, Lauren E. Wilson, PhD, Rebecca A. Previs MD, Anjali Gupta, Ashwini Joshi MPH, Bin Huang PhD, Maria Pisu, PhD, Margaret Liang MD, Kevin C. Ward PhD, Maria J. Schymura PhD, Andrew Berchuck MD, and Tomi F. Akinyemiju PhD

Previous DCI Newsmakers